You may be interested in the following article which only showed an association between stroke and LVEF when LVEF was < 15%. I'm not 100% sure, but I don't think many participants in the DREAM-HF trial, if any, met this criteria. I expect Mesoblast would also be required to adjust their trial results for any confounding variables, including ejection fraction, when presenting their results to the FDA.
Title: Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure
https://www.ahajournals.org/doi/10.1161/STROKEAHA.116.013679
Silviu Itescu The Legend, page-302
-
- There are more pages in this discussion • 579 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.015(1.49%) |
Mkt cap ! $1.164B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | 94.0¢ | $11.76M | 11.90M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 206912 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 37637 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |